These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 33336742)

  • 21. MicroRNA-301a inhibits the progression of osteosarcoma by regulating DEC2.
    Wu H; Yu Z; Chen Q; Li D; Chen W
    J BUON; 2020; 25(2):1013-1021. PubMed ID: 32521900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircRNA_100876 promote proliferation and metastasis of breast cancer cells through adsorbing microRNA-361-3p in a sponge form.
    Yang CY; Zhang FX; He JN; Wang SQ
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6962-6970. PubMed ID: 31486496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-328-3p inhibits malignant progression of hepatocellular carcinoma by regulating MMP-9 level.
    Li JZ; Li J; Liu BZ
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9331-9340. PubMed ID: 31773692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
    Xu FY; Xu X; Hu XD
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
    Luo X; Song Y; Tang L; Sun DH; Ji DG
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-588 regulates migration capacity and invasiveness of renal cancer cells by targeting EIF5A2.
    Dong JS; Wu B; Zha ZL
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10248-10256. PubMed ID: 31841179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiRNA-106a promotes breast cancer progression by regulating DAX-1.
    Liu C; Song YH; Mao Y; Wang HB; Nie G
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1574-1583. PubMed ID: 30840280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-124 inhibits proliferation and metastasis of esophageal cancer via negatively regulating NRP1.
    Zang RK; Ma JB; Liang YC; Wang Y; Hu SL; Zhang Y; Dong W; Zhang W; Hu LK
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4532-4541. PubMed ID: 30058693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
    Gao WY; Yang G; Wang J; He JM; Wang P
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
    He SZ; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124.
    Zhang S; Liu Y; Liu Z; Zhang Y; Chen G; Li K; Tang K
    J BUON; 2019; 24(6):2402-2410. PubMed ID: 31983112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA XIST promotes migration of Wilms' tumor cells through modulation of microRNA-193a-5p.
    Yao FZ; He R; Jiang YC; Hou Y; Qian D
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):9889-9898. PubMed ID: 33090392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiRNA-8073 targets ZnT1 to inhibit malignant progression of ovarian cancer.
    Zhang L; Wang YH; Wang L
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6062-6069. PubMed ID: 31364107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-195-5p inhibits malignant progression of gallbladder cancer by regulating Wnt3a.
    Sun HD
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7635-7642. PubMed ID: 34982425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CRNDE promotes the development of Wilms' tumor by regulating microRNA-424.
    Cui WW; Sun YL; Chen C; Feng RR; Xu W; Meng JJ; Zhang K
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1088-1097. PubMed ID: 32096178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ_0000064 adsorption of microRNA-143 promotes malignant progression of hepatocellular carcinoma.
    Wu L; Xu XM; Li Y; Fan L
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9321-9330. PubMed ID: 31773699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism of LncRNA FOXC2-AC1 promoting lung cancer metastasis by regulating miR-107.
    Wu XF; Lu JT; Chen W; Wang N; Meng JC; Zhou YH
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):690-698. PubMed ID: 30720176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
    Ma JB; Hu SL; Zang RK; Su Y; Liang YC; Wang Y
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.